Safety of infliximab in Crohn's disease: a large single-center experience

H Hamzaoglu, J Cooper, M Alsahli… - Inflammatory bowel …, 2010 - academic.oup.com
Background The aim of this study was to evaluate the short-and long-term safety experience
of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. Methods The …
被引用次数：49 相关文章

Safety of infliximab in Crohn's disease: a large single-center experience

H Hamzaoglu, J Cooper, M Alsahli… - Inflammatory …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The aim of this study was to evaluate the short-and long-term safety experience
of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. Methods The …

[引用][C] Safety of infliximab in Crohnʼs disease

H Hamzaoglu, J Cooper, M Alsahli… - Inflammatory Bowel …, 2010 - cir.nii.ac.jp

Safety of infliximab in Crohn's disease: a large single-center experience.

H Hamzaoglu, J Cooper, M Alsahli… - Inflammatory Bowel …, 2010 - europepmc.org
Background The aim of this study was to evaluate the short-and long-term safety experience
of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. Methods The …

Safety of infliximab in Crohn's disease: A large single‐center experience

H Hamzaoglu, J Cooper, M Alsahli… - Inflammatory Bowel …, 2010 - Wiley Online Library
Background: The aim of this study was to evaluate the short‐and long‐term safety
experience of infliximab treatment in patients with Crohn's disease (CD) in clinical practice …

[引用][C] Safety of Infliximab in Crohn's Disease: A Large Single-center Experience

H HAMZAOGLU, J COOPER, M ALSAHLI… - Inflammatory bowel …, 2010 - Wiley